Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines.

MLA

Patel, Forum, et al. “Detailed Protocol for Administration of Intralesional IL-2 for the Treatment of Stage IIIc and IV M1a Metastatic Melanoma Based on Current NCCN Guidelines.” Dermatology Online Journal, vol. 20, no. 11, Nov. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25419744&authtype=sso&custid=ns315887.

APA

Patel, F., Wilken, R., Burrall, B., Martinez, S., Wells, V., King, B., & Maverakis, E. (2014). Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines. Dermatology Online Journal, 20(11).

Chicago

Patel, Forum, Reason Wilken, Barbara Burrall, Steve Martinez, Victoria Wells, Brett King, and Emanual Maverakis. 2014. “Detailed Protocol for Administration of Intralesional IL-2 for the Treatment of Stage IIIc and IV M1a Metastatic Melanoma Based on Current NCCN Guidelines.” Dermatology Online Journal 20 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25419744&authtype=sso&custid=ns315887.